Program:
The development of small molecule combinatorial libraries has given new meaning to what constitutes high throughput rates for drug screening assays, thereby putting added pressure on sample handling, tracking, analytical testing and selection of initial leads for further development. Any screening process, however, is only as good as the quality of the targets and assays being used, and thus this aspect of the process also deserves careful consideration. The most successful efforts will be those which best integrate these and other factors into a cohesive screening program, for which examples from a number of biotech and pharmaceutical companies will be provided. As in previous years, this event will feature a major tradeshow of technology and equipment vendors.
Registration :
Cambridge Healthtech Institute
1037 Chestnut Street
Newton Upper Falls, MA 02164 USA
tel: 617-630-1300
fax: 617-640-1325
Deadline for Abstracts: 12/95
Email for Requests and Registration: chi@healthtech.com